These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9431367)

  • 61. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
    Barberán J; Aguilar L; Carroquino G; Giménez MJ; Sánchez B; Martínez D; Prieto J
    Am J Med; 2006 Nov; 119(11):993.e7-10. PubMed ID: 17071171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The levels of vancomycin in the blood and the wound after the local treatment of bone and soft-tissue infection with antibiotic-loaded calcium sulphate as carrier material.
    Wahl P; Guidi M; Benninger E; Rönn K; Gautier E; Buclin T; Magnin JL; Livio F
    Bone Joint J; 2017 Nov; 99-B(11):1537-1544. PubMed ID: 29092996
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Safety of oral antibiotics in staphylococcal device-associated bone and joint infections].
    Ngo Bell EC; Forestier E; Montbarbon E; Ferry-Blanco C; Rogeaux O
    Med Mal Infect; 2014 Aug; 44(8):393-5. PubMed ID: 25153917
    [No Abstract]   [Full Text] [Related]  

  • 64. [Prosthetic joint infection: new developments in diagnosis and treatment].
    Trampuz A; Perka C; Borens O
    Dtsch Med Wochenschr; 2013 Aug; 138(31-32):1571-3. PubMed ID: 23884740
    [No Abstract]   [Full Text] [Related]  

  • 65. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey.
    Johannsson B; Taylor J; Clark CR; Shamsuddin H; Beekmann SE; Polgreen P;
    Diagn Microbiol Infect Dis; 2010 Jan; 66(1):16-23. PubMed ID: 19782494
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone.
    Aboltins CA; Dowsey MM; Buising KL; Peel TN; Daffy JR; Choong PF; Stanley PA
    Clin Microbiol Infect; 2011 Jun; 17(6):862-7. PubMed ID: 20825437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections.
    Herrera S; Sorlí L; Horcajada JP
    Med Clin (Barc); 2017 Sep; 149(5):223-224. PubMed ID: 28602211
    [No Abstract]   [Full Text] [Related]  

  • 69. Old antimicrobials and Gram-positive cocci through the example of infective endocarditis and bone and joint infections.
    Seng P; Amrane S; Million M; Stein A
    Int J Antimicrob Agents; 2017 May; 49(5):558-564. PubMed ID: 28365430
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serratia marcescens as a cause of postoperative infection in a total joint implant.
    Brink D; Stuck R; Streit N; Sternberg L
    J Foot Ankle Surg; 1993; 32(2):227-31. PubMed ID: 8318980
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry.
    Malizos K; Sarma J; Seaton RA; Militz M; Menichetti F; Riccio G; Gaudias J; Trostmann U; Pathan R; Hamed K
    Eur J Clin Microbiol Infect Dis; 2016 Jan; 35(1):111-8. PubMed ID: 26563898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Experimental osteomyelitis: what have we learned from animal studies about the systemic treatment of osteomyelitis?
    Lazzarini L; Overgaard KA; Conti E; Shirtliff ME
    J Chemother; 2006 Oct; 18(5):451-60. PubMed ID: 17127219
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Results with Refobacin-Palacos in the changing of infected prostheses. Results of prostheses exchange under cover of Refobacin-Palacos in Hamburg].
    Röttger J; Buchholz HW; Engelbrecht E; Siegel A
    Aktuelle Probl Chir Orthop; 1979; (12):211-3. PubMed ID: 36787
    [No Abstract]   [Full Text] [Related]  

  • 74. Prosthesis selection.
    Diaz-Ledezma C; Parvizi J; Zhou Y; Antoci V; Ducheyne P; Freiberg A; Garcia Rangel G; Han SB; Hickok N; Higuera C; Ketonis C; Korkusuz F; Kruczynski J; Macule F; Markuszewski J; Marín-Peña O; Nathwani D; Noble P; Ong K; Ono N; Parvizi MS; Post Z; Rivero-Boschert S; Schaer T; Shapiro I
    J Arthroplasty; 2014 Feb; 29(2 Suppl):71-6. PubMed ID: 24360496
    [No Abstract]   [Full Text] [Related]  

  • 75. Antibiotic prophylaxis to reduce the risk of joint implant contamination during dental surgery seems unnecessary.
    Legout L; Beltrand E; Migaud H; Senneville E
    Orthop Traumatol Surg Res; 2012 Dec; 98(8):910-4. PubMed ID: 23158782
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Three-times weekly teicoplanin as outpatient treatment of chronic osteoarticular infections.
    Tascini C; Tagliaferri E; Di Paolo A; Ciofi L; Del Tacca M; Lambelet P; Menichetti F
    J Chemother; 2009 Aug; 21(4):421-5. PubMed ID: 19622461
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Current treatment of Gram-positive infections: from experimental models to clinical experience after approval of new drugs].
    Barberán J
    Med Clin (Barc); 2010 Dec; 135 Suppl 3():5-9. PubMed ID: 21477698
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.
    Peeters O; Ferry T; Ader F; Boibieux A; Braun E; Bouaziz A; Karsenty J; Forestier E; Laurent F; Lustig S; Chidiac C; Valour F;
    BMC Infect Dis; 2016 Nov; 16(1):622. PubMed ID: 27809799
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clarithromycin destroys biofilms and enhances bactericidal agents in the treatment of Pseudomonas aeruginosa osteomyelitis.
    Kandemir O; Oztuna V; Milcan A; Bayramoğlu A; Celik HH; Bayarslan C; Kaya A
    Clin Orthop Relat Res; 2005 Jan; (430):171-5. PubMed ID: 15662320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.